General MedicationsOPHTHALMICGeneric

ALBALON

NAPHAZOLINE HYDROCHLORIDE

Standard Dose

0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview ALBALON is listed in Drugs@FDA under application 080248 (ANDA).

Marketing status: Discontinued Active ingredient NAPHAZOLINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2002-11-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview ALBALON is listed in Drugs@FDA under application 080248 (ANDA). Marketing status: Discontinued Active ingredient NAPHAZOLINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2002-11-15 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.